Smoking may have negative effect on breast cancer survival
the ONA take:
Premenopausal women with breast cancer are at increased risk of dying if they smoke, according to new research from Japanese investigators. This prospective study followed 848 women with breast cancer for a median of 6.7 years.
Study findings indicate that premenopausal women who smoked for more than 21.5 years had a 3.1 times higher risk of dying from any cause and a 3.4 times higher risk of dying from breast cancer.
In addition, the increased risk was especially relevant to women whose cancers expressed both the estrogen receptor and the progesterone receptor.
The authors hope their study will help in advising patients about how their smoking might affect their outcome, and encourage them to quit smoking.
Premenopausal women with breast cancer are at increased risk of dying if they smoke.
Sign Up for Free e-newsletters
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Modified XELIRI Noninferior to FOLFIRI for OS in Metastatic Colorectal Cancer
- Nabilone Improves Cancer-Associated Anorexia in Lung Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|